179 related articles for article (PubMed ID: 8650771)
1. [Lamotrigine treatment of 92 patients with intractable epilepsy].
Karlsborg M; Gram L; Dam M
Ugeskr Laeger; 1996 Apr; 158(14):1969-72. PubMed ID: 8650771
[TBL] [Abstract][Full Text] [Related]
2. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of lamotrigine monotherapy in children and adolescents with epilepsy.
Valencia I; Piñol-Ripoll G; Khurana DS; Hardison HH; Kothare SV; Melvin JJ; Marks HG; Legido A
Eur J Paediatr Neurol; 2009 Mar; 13(2):141-5. PubMed ID: 18585941
[TBL] [Abstract][Full Text] [Related]
4. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy.
Moeller JJ; Rahey SR; Sadler RM
Epilepsia; 2009 Mar; 50(3):475-9. PubMed ID: 19054403
[TBL] [Abstract][Full Text] [Related]
5. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
[TBL] [Abstract][Full Text] [Related]
6. A survey comparing lamotrigine and vigabatrin in everyday clinical practice.
Schapel G; Chadwick D
Seizure; 1996 Dec; 5(4):267-70. PubMed ID: 8952011
[TBL] [Abstract][Full Text] [Related]
7. [Lamotrigine in refractory partial and general epilepsies].
Mauri-Llerda JA; Tejero C; Espada F; Iñiguez C; Morales F
Rev Neurol; 2001 Jan 1-15; 32(1):42-5. PubMed ID: 11293097
[TBL] [Abstract][Full Text] [Related]
8. [Effectiveness and role of lamotrigine in the paradigm shift towards new antiepileptic drugs: a therapeutic strategy proposed after an investigation of a large number of cases at a single hospital].
Yamamoto T; Yamazoe T; Fujimoto A; Kobayashi R; Yokota T; Okanishi T; Uchiyama G; Ohashi T; Tanaka T; Enoki H
Brain Nerve; 2014 Jan; 66(1):59-69. PubMed ID: 24371132
[TBL] [Abstract][Full Text] [Related]
9. The LAM-SAFE Study: lamotrigine versus carbamazepine or valproic acid in newly diagnosed focal and generalised epilepsies in adolescents and adults.
Steinhoff BJ; Ueberall MA; Siemes H; Kurlemann G; Schmitz B; Bergmann L;
Seizure; 2005 Dec; 14(8):597-605. PubMed ID: 16278088
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine therapy of epilepsy in tuberous sclerosis.
Franz DN; Tudor C; Leonard J; Egelhoff JC; Byars A; Valerius K; Sethuraman G
Epilepsia; 2001 Jul; 42(7):935-40. PubMed ID: 11488895
[TBL] [Abstract][Full Text] [Related]
11. A pharmacoepidemiologic study of factors influencing the outcome of treatment with lamotrigine in chronic epilepsy.
Wong IC; Mawer GE; Sander JW; Lhatoo SD
Epilepsia; 2001 Oct; 42(10):1354-8. PubMed ID: 11737172
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of childhood epilepsy with lamotrigine. An evaluation of efficacy in different types of epilepsy].
Uldall PV; Sommer B
Ugeskr Laeger; 1996 Apr; 158(14):1973-6. PubMed ID: 8650772
[TBL] [Abstract][Full Text] [Related]
13. Prospective, open-label, add-on study of lamotrigine in 56 children with intractable generalized epilepsy.
Farrell K; Connolly MB; Munn R; Peng S; MacWilliam LM
Pediatr Neurol; 1997 Apr; 16(3):201-5. PubMed ID: 9165509
[TBL] [Abstract][Full Text] [Related]
14. Lamotrigine and seizure aggravation in severe myoclonic epilepsy.
Guerrini R; Dravet C; Genton P; Belmonte A; Kaminska A; Dulac O
Epilepsia; 1998 May; 39(5):508-12. PubMed ID: 9596203
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of add-on treatment with lamotrigine in partial epilepsy.
Smith D; Baker G; Davies G; Dewey M; Chadwick DW
Epilepsia; 1993; 34(2):312-22. PubMed ID: 8453943
[TBL] [Abstract][Full Text] [Related]
16. Role of vigabatrin and lamotrigine in treatment of childhood epileptic syndromes.
Bélanger S; Coulombe G; Carmant L
Epilepsia; 1998 Aug; 39(8):878-83. PubMed ID: 9701380
[TBL] [Abstract][Full Text] [Related]
17. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
[TBL] [Abstract][Full Text] [Related]
18. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
Ramey P; Osborn M; Abou-Khalil B
Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
[TBL] [Abstract][Full Text] [Related]
19. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
[TBL] [Abstract][Full Text] [Related]
20. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
